- Home
- HTH vs CNTA Comparison
HTH vs CNTA Comparison
Compare HTH & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTH
- CNTA
- Stock Information
- Founded
- HTH 1998
- CNTA 2020
- Country
- HTH United States
- CNTA United Kingdom
- Employees
- HTH N/A
- CNTA N/A
- Industry
- HTH Major Banks
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- HTH Finance
- CNTA Health Care
- Exchange
- HTH Nasdaq
- CNTA Nasdaq
- Market Cap
- HTH 1.9B
- CNTA 1.8B
- IPO Year
- HTH 2004
- CNTA 2021
- Fundamental
- Price
- HTH $30.25
- CNTA $12.30
- Analyst Decision
- HTH Hold
- CNTA Strong Buy
- Analyst Count
- HTH 2
- CNTA 10
- Target Price
- HTH $33.00
- CNTA $26.11
- AVG Volume (30 Days)
- HTH 338.1K
- CNTA 617.5K
- Earning Date
- HTH 04-24-2025
- CNTA 05-20-2025
- Dividend Yield
- HTH 2.38%
- CNTA N/A
- EPS Growth
- HTH 15.07
- CNTA N/A
- EPS
- HTH 1.97
- CNTA N/A
- Revenue
- HTH $1,208,822,000.00
- CNTA N/A
- Revenue This Year
- HTH N/A
- CNTA N/A
- Revenue Next Year
- HTH $3.14
- CNTA N/A
- P/E Ratio
- HTH $15.37
- CNTA N/A
- Revenue Growth
- HTH 2.13
- CNTA N/A
- 52 Week Low
- HTH $26.67
- CNTA $7.75
- 52 Week High
- HTH $35.32
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- HTH 59.19
- CNTA 40.97
- Support Level
- HTH $29.53
- CNTA $11.88
- Resistance Level
- HTH $30.53
- CNTA $14.39
- Average True Range (ATR)
- HTH 0.76
- CNTA 0.79
- MACD
- HTH 0.20
- CNTA -0.00
- Stochastic Oscillator
- HTH 84.18
- CNTA 18.68
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.